InvestorsHub Logo
Followers 12
Posts 619
Boards Moderated 0
Alias Born 12/14/2018

Re: None

Saturday, 01/19/2019 11:24:12 AM

Saturday, January 19, 2019 11:24:12 AM

Post# of 693957
Neoantigen vaccine generates intratumoral T-cell response in Phase 1b glioblastoma trial

https://www.nature.com/articles/s41586-018-0792-9

Patients who did not receive dexamethasone—a highly potent corticosteroid that is frequently prescribed to treat cerebral oedema in patients with glioblastoma—generated circulating polyfunctional neoantigen-specific CD4+ and CD8+ T cell responses that were enriched in a memory phenotype and showed an increase in the number of tumour-infiltrating T cells.



Presumably whole tumor lysate should work better but interesting nonetheless.

Let’s see if jondoeuk is awake this morningwink



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News